Rethinking disease progression in MS

We know that relapses, being a defining clinical feature of MS, contribute to meaningful neurological disability over the short term. However, their contribution towards long-term disability progression is controversial: long-term disability progression studies and natural history studies have delivered conflicting results. In a recent large MSBase study, a high annualised relapse rate, particu